AU Patent

AU2016349169B2 — Physically and chemically stable oral suspensions of Givinostat

Assigned to Italfarmaco SpA · Expires 2021-11-11 · 5y expired

What this patent protects

Physically and chemically stable oral liquid formulations of Givinostat (Diethyl- [6-(4- hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride) are disclosed, together with methods for the preparation thereof. Such oral formulations are in the form …

USPTO Abstract

Physically and chemically stable oral liquid formulations of Givinostat (Diethyl- [6-(4- hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride) are disclosed, together with methods for the preparation thereof. Such oral formulations are in the form of aqueous suspensions and contain Givinostat and/or pharmaceutically acceptable salts and/or derivatives thereof, at least a wetting agent and/or at least a density-imparting agent. Such formulations are suitable for oral administration for systemic therapeutic action.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016349169B2
Jurisdiction
AU
Classification
—
Expires
2021-11-11
Drug substance claim
No
Drug product claim
No
Assignee
Italfarmaco SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.